I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Table_4_Effects of Wee1 inhibitor adavosertib on patient-de..:
Pia Roering
;
Arafat Siddiqui
;
Vanina D. Heuser
...
doi:10.3389/fonc.2022.954430.s010. , 2022
Link:
https://doi.org/10.3389/fonc.2022.954430.s010
RT Journal T1
Table_4_Effects of Wee1 inhibitor adavosertib on patient-derived high-grade serous ovarian cancer cells are multiple and independent of homologous recombination status.xlsx
UL https://suche.suub.uni-bremen.de/peid=base-ftfrontimediafig:oai:figshare.com:article_20546781&Exemplar=1&LAN=DE A1 Pia Roering A1 Arafat Siddiqui A1 Vanina D. Heuser A1 Swapnil Potdar A1 Piia Mikkonen A1 Jaana Oikkonen A1 Yilin Li A1 Sanna Pikkusaari A1 Krister Wennerberg A1 Johanna Hynninen A1 Seija Grenman A1 Kaisa Huhtinen A1 Annika Auranen A1 Olli Carpén A1 Katja Kaipio YR 2022 K1 Cancer K1 Cancer Cell Biology K1 Cancer Diagnosis K1 Cancer Genetics K1 Cancer Therapy (excl. Chemotherapy and Radiation Therapy) K1 Chemotherapy K1 Haematological Tumours K1 Molecular Targets K1 Radiation Therapy K1 Solid Tumours K1 Oncology and Carcinogenesis not elsewhere classified K1 adavosertib K1 patient-derived cell line K1 high-grade serous ovarian cancer (HGSOC) K1 homologous recombination (HR) K1 drug screen K1 platinum-resistant ovarian cancer K1 homologous recombination deficiency (HRD) K1 homologous recombination proficient JF doi:10.3389/fonc.2022.954430.s010 LK http://dx.doi.org/https://doi.org/10.3389/fonc.2022.954430.s010 DO https://doi.org/10.3389/fonc.2022.954430.s010 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)